APA (7th ed.) Citation

Prince, E. W., & Remke, M. (2016). Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma. OncoTarget, 7(33), . https://doi.org/10.18632/oncotarget.10692

Chicago Style (17th ed.) Citation

Prince, Eric W., and Marc Remke. "Checkpoint Kinase 1 Expression Is an Adverse Prognostic Marker and Therapeutic Target in MYC-driven Medulloblastoma." OncoTarget 7, no. 33 (2016). https://doi.org/10.18632/oncotarget.10692.

MLA (9th ed.) Citation

Prince, Eric W., and Marc Remke. "Checkpoint Kinase 1 Expression Is an Adverse Prognostic Marker and Therapeutic Target in MYC-driven Medulloblastoma." OncoTarget, vol. 7, no. 33, 2016, https://doi.org/10.18632/oncotarget.10692.